Astera Labs, Inc. $ALAB Shares Sold by Wealth Management Partners LLC

Wealth Management Partners LLC cut its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 8.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 23,627 shares of the company’s stock after selling 2,169 shares during the period. Astera Labs accounts for approximately 1.9% of Wealth Management Partners LLC’s portfolio, making the stock its 13th largest holding. Wealth Management Partners LLC’s holdings in Astera Labs were worth $8,411,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of ALAB. Crossmark Global Holdings Inc. grew its stake in Astera Labs by 19.0% during the third quarter. Crossmark Global Holdings Inc. now owns 1,994 shares of the company’s stock valued at $710,000 after acquiring an additional 318 shares in the last quarter. Capstone Capital Management Ltd bought a new stake in Astera Labs during the 3rd quarter worth approximately $944,000. Nisa Investment Advisors LLC lifted its stake in Astera Labs by 11.8% in the 3rd quarter. Nisa Investment Advisors LLC now owns 9,327 shares of the company’s stock worth $3,320,000 after purchasing an additional 983 shares in the last quarter. Integrated Advisors Network LLC lifted its stake in Astera Labs by 4.8% in the 3rd quarter. Integrated Advisors Network LLC now owns 983 shares of the company’s stock worth $350,000 after purchasing an additional 45 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. lifted its stake in Astera Labs by 5.3% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 151,807 shares of the company’s stock worth $54,039,000 after purchasing an additional 7,644 shares in the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. Citigroup downgraded shares of Astera Labs from a “buy” rating to a “hold” rating in a report on Friday, October 9th. UBS Group reaffirmed a “neutral” rating and issued a $425.00 price target on shares of Astera Labs in a report on Wednesday, August 5th. Jefferies Financial Group upped their price target on shares of Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Morgan Stanley increased their price objective on Astera Labs to $335.00 and gave the stock an “overweight” rating in a research report on Monday, August 3rd. Finally, Roth Capital reiterated a “buy” rating and issued a $450.00 price objective on shares of Astera Labs in a research report on Wednesday, August 5th. Eleven equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to MarketBeat.com, Astera Labs currently has an average rating of “Moderate Buy” and a consensus target price of $344.17.

Astera Labs Trading Up 1.8%

Shares of ALAB opened at $290.06 on Thursday. The company has a market cap of $50.32 billion, a PE ratio of 183.74 and a beta of 3.68. The stock has a 50-day moving average price of $313.13 and a 200-day moving average price of $302.11. Astera Labs, Inc. has a 12-month low of $97.89 and a 12-month high of $499.48.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.69 by $0.11. The company had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. Astera Labs’s revenue was up 104.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, analysts predict that Astera Labs, Inc. will post 2.70 earnings per share for the current year.

Insider Buying and Selling at Astera Labs

In other news, General Counsel Philip Mazzara sold 6,801 shares of the firm’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the sale, the general counsel owned 96,542 shares in the company, valued at approximately $32,872,551. This trade represents a 6.58% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction on Wednesday, October 7th. The stock was sold at an average price of $376.06, for a total transaction of $3,382,283.64. Following the sale, the director directly owned 2,648 shares of the company’s stock, valued at $995,806.88. This represents a 77.25% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 408,558 shares of company stock valued at $127,306,034 over the last quarter. Company insiders own 10.40% of the company’s stock.

Astera Labs Company Profile

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.